HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 23 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $4,000 | -42.9% | 6,966 | 0.0% | 0.00% | -50.0% |
Q2 2022 | $7,000 | -30.0% | 6,966 | 0.0% | 0.01% | -14.3% |
Q1 2022 | $10,000 | -73.7% | 6,966 | 0.0% | 0.01% | -70.8% |
Q4 2021 | $38,000 | -5.0% | 6,966 | 0.0% | 0.02% | -17.2% |
Q3 2021 | $40,000 | 0.0% | 6,966 | 0.0% | 0.03% | 0.0% |
Q2 2021 | $40,000 | +5.3% | 6,966 | 0.0% | 0.03% | -3.3% |
Q1 2021 | $38,000 | +18.8% | 6,966 | +4.5% | 0.03% | +11.1% |
Q4 2020 | $32,000 | – | 6,666 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|